Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2012 · —
Revenue$1.87B$1.87B−3.1% vs Q1 2011 Net Income$113.00M$113.00M+145.7% vs Q1 2011 EPS Diluted$0.08$0.08+166.7% vs Q1 2011 Gross Profit$1,235,000,000−4.6% Operating Income$196,000,000−39.1% Operating Cash Flow$212,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
N/M
Free Cash Flowderived$146,000,000N/M Margins · derivedGross margin66.2%−1.0 pt vs Q1 2011
Operating margin10.5%−6.2 pt vs Q1 2011
Net margin6.1%+3.7 pt vs Q1 2011